Product Information
MINIVELLE 0.025 MG PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $11.5876 per EA under NDC 68968662508. Its NADAC has been published 338 times since Jul 22, 2015.
FDA first approved this application on Oct 29, 2012. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.025 mg/d
Manufacturer
Noven Therapeutics, LLCNDC
68968662508
Classification
Brand
Dosage Form
FILM, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA203752FDA Approved
10/29/2012
TE Code
AB3
On Market Since
12/20/2012
Pharmacological Classes
Price Statistics
The NADAC for MINIVELLE 0.025 MG PATCH has been published 338 times since Jul 22, 2015, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5876 per EA |
|---|---|
| All-time high | $27.9114 (Oct 16, 2024) |
| All-time low | $11.5701 (Dec 17, 2025) |
| 52-week high | $11.5936 |
| 52-week low | $11.5701 |
| Median price | $17.7725 |
| Average price | $17.7009 |
| Largest weekly change | -58.3% (Apr 2, 2025) |
| Weeks tracked | 338 |
| Tracking since | Jul 22, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINIVELLE 0.025 MG PATCH?
The current National Average Drug Acquisition Cost (NADAC) for MINIVELLE 0.025 MG PATCH, manufactured by Noven Therapeutics, LLC, is $11.5876 per EA (NDC 68968662508), effective Sep 30, 2026.
How has the price of MINIVELLE 0.025 MG PATCH changed over time?
Over the history we have for it, the NADAC for MINIVELLE 0.025 MG PATCH has declined 12.9%. It has been tracked across 338 weekly CMS publications since Jul 22, 2015.
What are the highest and lowest recorded NADAC prices for MINIVELLE 0.025 MG PATCH?
Since Jul 22, 2015, the NADAC for MINIVELLE 0.025 MG PATCH has ranged from a low of $11.5701 (Dec 17, 2025) to a high of $27.9114 (Oct 16, 2024), with a median of $17.7725 per EA.
Are there cheaper alternatives to MINIVELLE 0.025 MG PATCH?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESTRADIOL 0.025 MG PATCH(2/WK), is $7.7577 per EA — about 33% below MINIVELLE 0.025 MG PATCH.
Who manufactures MINIVELLE 0.025 MG PATCH?
MINIVELLE 0.025 MG PATCH (NDC 68968662508) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.